Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease

Heart

Volumn 85, Issue 6, 2001, Pages 655-661

  Van Domburg, R T ^a   Sozzi, F B ^a   Poldermans, D ^a   Bax, J J ^a   Roelandt, J R T C ^a   Elhendy, A ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

Author keywords

Coronary artery disease; Exercise stress test; Hypertension; Myocardial perfusion

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELIABILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034768263     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on exercise testing)
2. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease
3. Technetium 99m sestamibi in the assessment of chronic coronary artery disease
4. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
5. The role of nuclear cardiology in hypertension
6. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease
7. Segmentary coronary reserve in hypertensive patients with echocardiographic left ventricular hypertrophy, gammagraphic ischemia and normal coronary angiography
8. Alteration in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography
9. The heart in hypertension
10. Pathophysiology of myocardial perfusion in hypertension
11. Evaluation of coronary flow reserve in hypertensive patients by dipyridamole transesophageal Doppler echocardiography
12. Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis: Correlation with dobutamine-atropine stress test
13. Measurement of left ventricular thickness and mass by echocardiography
14. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
15. Echocardiographic criteria of left ventricular hypertrophy: The Framingham Heart Study
16. Assessment of cardiac status in hypertensive patients
17. Comparison of exercise perfusion and ventricular function imaging: An analysis of factors affecting the diagnostic accuracy of each technique
18. Absence of defects in SPECT thallium 201 myocardial images in patients with systemic hypertension and left ventricular hypertrophy
19. Thallium 201 stress imaging in hypertensive patients
20. The effect of systemic hypertension on exercise tomographic thallium-201 imaging in the absence of electrocardiographic left ventricular hypertrophy
21. Diagnostic accuracy of exercise thallium-201 scintigraphy in men with asymptomatic essential hypertension
22. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test
23. Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing and normal coronary arteriograms
24. Comparison of dobutamine stress echocardiography and 99m-technetium sestamibi SPET for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy
25. Myocardial perfusion abnormalities in treated hypertensive patients without known coronary artery disease
26. Tc-99m sestamibi myocardial SPECT in syndrome X
27. Cardiovascular structural alterations in hypertension: Effect of treatment
28. Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men
29. Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms
30. Usefulness of 99mTc-MIBI stress myocardial SPECT bull's-eye quantification in coronary artery disease
31. Correlation of 99Tcm-sestamibi SPECT with coronary angiography in general hospital practice
32. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201T1 imaging and coronary angiography in a phase III multicenrer trial
33. Accuracy of 99mTc-tetrofosmin myocardial tomography in the evaluation of coronary artery disease
34. Technetium-99m retrofosmin rest/stress myocardial SPET with a same-day 2-hour protocol: Comparison with coronary angiography. A Spanish-Portuguese multicentre clinical trial
35. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease
36. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: Intraindividual comparison with technetium 99m-sestamibi